Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle

Geron-300x2212

We’ve all been closely following Geron and its work on ES cells. This morning there was a fantastic session here at the ASGCT meeting in Seattle on Clinical Trials on Stem Cells. Talk by Geron One of the speakers was Geron VP, Jane Lebkoswki, PhD: Development of Human Embryonic Stem Cell-Based Therapies for Treatment of […]

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle Read More »

Summary of George Daley talk on iPS cells today in Seattle

The best talk today was the keynote address by Dr. George Daley focused mostly on iPS cells. Dr. Daley is one of the world’s experts on iPS cells and pluripotent stem cells more generally. He covered many interesting elements of the iPS cell field including the genetic mutations that seem to occur during the reprogramming

Summary of George Daley talk on iPS cells today in Seattle Read More »

News on iPS cells from some top scientists at ASGCT meeting today

There were three talks today on iPS cells here at the American Society for Gene and Cell Therapy meeting or ASGCT meeting in Seattle. Dr. James Ellis made the interesting case that it may be preferable to make iPS cells using genetic methods (while everyone else seems to be saying that non-genetic methods will be better).

News on iPS cells from some top scientists at ASGCT meeting today Read More »

Why invest in stem cells? Progress, Patients, and Patents

Why invest in stem cells? Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of

Why invest in stem cells? Progress, Patients, and Patents Read More »

Subscribe to Our Newsletter

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.